Skip to main content

Discussion session: biomarker trials

Various speakers In a combined presentation and discussion session, representatives from academia and industry discuss the role of Biomarker trial design and implementation, to improve health by improving trials.

Author information

Consortia

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Discussion session: biomarker trials. Trials 16, I2 (2015). https://doi.org/10.1186/1745-6215-16-S2-I2

Download citation

Keywords

  • Public Health
  • Trial Design
  • Discussion Session
  • Combine Presentation